Nifty Pharma Prediction for Monday 7 September 2026
- September 4, 2026
- Posted by: Kunal Singla
- Category: Predictions
Nifty Pharma: 26,478.10 (-0.68%). High 26,695.00. Low 26,461.40. VIX 10.79. Support 26,350.00. Resistance 26,680.00. Next trading day is Monday 7 Sep.
Quick Answer
The Monday’s Nifty Pharma outlook for 7 September 2026 is cautious with immediate support at 26,350.00 and resistance at 26,680.00. Nifty Pharma closed at 26,478.10 on Friday, 4 September, -0.68% from the previous close. Since Indian markets are closed on Saturday and Sunday, Monday is the next trading session for the Monday’s pharma session. Ankit Jaiswal of Univest flags 26,350.00 as the must-hold level for the pharma index Monday forecast.
The Nifty Pharma Monday outlook for 7 September 2026 is shaped by Friday’s session, the last trading day before the weekend break. Nifty Pharma closed at 26,478.10, -0.68 percent, as the broader market saw Sensex snap its four session losing streak, gaining 0.48 percent, aided by dovish Fed commentary that eased September rate hike concerns. Nifty Pharma fell 0.68 percent on Friday, giving back some of its recent defensive strength even as the broader market recovered on dovish Fed commentary. The Monday’s Nifty Pharma outlook for Monday carries an important nuance: with markets closed Saturday and Sunday, the usual overnight gap becomes an extended weekend gap, requiring closer attention to global cues.
Ankit Jaiswal, equity research analyst at Univest, notes that the Monday’s pharma session is shaped by both sector-specific factors from Friday’s session and the broader positive market context following Fed Governor Christopher Waller’s dovish remarks, which reduced rate hike odds and lifted global equities. A substantial $136 billion cumulative NRI deposit mobilisation through the RBI’s swap scheme has also bolstered India’s FX reserves, a supportive backdrop for the pharma index Monday forecast heading into Monday.
Click Here – Get Free Investment Predictions
Nifty Pharma Performance on 4 September 2026
| Metric | Value |
|---|---|
| Index Close | 26,478.10 |
| Change | -180.55 (-0.68%) |
| Day High | 26,695.00 |
| Day Low | 26,461.40 |
| Previous Close | 26,658.65 |
| India VIX | 10.79 (-4.85%) |
Nifty Pharma Prediction for Monday: Technical Analysis
The Nifty Pharma Monday outlook is grounded in Friday’s technical structure. The index’s position relative to its 50-day moving average zone remains a key input for the Monday’s Nifty Pharma outlook heading into Monday. RSI levels following Friday’s close will indicate whether the Monday’s pharma session is entering a fresh momentum phase or a consolidation range. The pharma index Monday forecast becomes bullish above 26,680.00 and bearish below 26,350.00 on a 15-minute NSE chart close once Monday’s session begins.
Nifty Pharma Support and Resistance for 7 September 2026
- Support 1: 26,350.00. Friday’s session floor zone. The Nifty Pharma Monday outlook stays constructive above this level on Monday.
- Support 2: 26,230.00. Stronger base. A breach here would materially weaken the Monday’s Nifty Pharma outlook.
- Resistance 1: 26,680.00. Friday’s intraday high zone. The Monday’s pharma session turns bullish above this level.
- Resistance 2: 26,820.00. Upper resistance. A sustained close here upgrades the pharma index Monday forecast significantly.
Stocks to Watch for Monday in Nifty Pharma Prediction
Key stocks to watch for Monday driving the Nifty Pharma Monday outlook include Sun Pharmaceutical Industries, Dr Reddys Laboratories, HDFC Bank, Reliance Industries, and ICICI Bank. Their individual performance on Monday will determine whether the Monday’s Nifty Pharma outlook outperforms or underperforms the Nifty 50 benchmark as trading resumes after the weekend.
Screen Nifty Pharma constituent stocks to watch for Monday on Univest Screener
Global and Domestic Factors for Nifty Pharma Prediction for Monday
The Monday’s pharma session for Monday is shaped by GIFT Nifty futures trading through the weekend and any global market developments over Saturday and Sunday, particularly any follow up to Fed Governor Waller’s dovish commentary. On the domestic side, DIIs bought Rs 4,977 crore on Thursday, more than double the Rs 2,346 crore FIIs sold, and this flow support could continue to underpin the pharma index Monday forecast into the new trading week.
Market commentary also flags that Brent crude remains near six week highs and the US-Iran conflict continues, a risk that could temper the otherwise positive backdrop for the Nifty Pharma Monday outlook if tensions escalate over the weekend.
Download the Univest iOS App or Univest Android App to track the nifty pharma prediction for monday in real time with live NSE data.
Risks to the Nifty Pharma Prediction for Monday
- A weekend escalation in the US-Iran conflict or a fresh crude oil price spike, which could offset the positive Fed driven sentiment behind the nifty pharma prediction for monday.
- A reversal of Friday’s sector specific momentum on profit booking, removing a key positive input for the nifty pharma prediction for monday.
- Any reversal in the dovish Fed tone if weekend US economic data surprises to the upside.
- Adverse global or domestic news specific to the nifty pharma sector altering the nifty pharma prediction for monday materially before Monday’s open.
Conclusion
The nifty pharma prediction for monday for 7 September 2026 is cautious, with Nifty Pharma at 26,478.10 and immediate support at 26,350.00. A hold above this level keeps the nifty pharma prediction for monday constructive for Monday. Ankit Jaiswal at Univest recommends tracking GIFT Nifty closely over the weekend and watching the first 15-minute candle of Monday’s session before committing to directional trades based on the nifty pharma prediction for monday. The stocks to watch for Monday within this sector will be the clearest signal for the nifty pharma prediction for monday direction on 7 September 2026.
Disclaimer: Investments in securities are subject to market risk. Read all related documents carefully before investing. This information is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.
Frequently Asked Questions
What is the nifty pharma prediction for monday on 7 September 2026?
Ans. The nifty pharma prediction for monday is cautious for 7 September 2026. Nifty Pharma closed at 26,478.10 on Friday, 4 September, -0.68%. Support is at 26,350.00 and resistance at 26,680.00. Since markets are closed Saturday and Sunday, Monday is the next trading session for the nifty pharma prediction for monday.
What is the key support for the nifty pharma prediction for monday?
Ans. The nifty pharma prediction for monday places immediate support at 26,350.00, based on Friday’s session floor. Secondary support is at 26,230.00. A hold above 26,350.00 on Monday keeps the nifty pharma prediction for monday constructive.
What resistance should traders watch for the nifty pharma prediction for monday?
Ans. The nifty pharma prediction for monday places first resistance at 26,680.00, near Friday’s intraday high. Upper resistance is at 26,820.00. A sustained close above 26,680.00 would upgrade the nifty pharma prediction for monday to bullish for 7 September 2026.
Why does the weekend matter for the nifty pharma prediction for monday?
Ans. Since Indian markets are closed on Saturday, 5 September, and Sunday, 6 September 2026, there is a two day gap before Monday’s session. GIFT Nifty futures trading through the weekend will be the primary directional guide for the nifty pharma prediction for monday, making it more sensitive to global news than a typical overnight prediction.
Which stocks will drive the nifty pharma prediction for monday?
Ans. Sun Pharmaceutical Industries, Dr Reddys Laboratories, HDFC Bank are among the key constituents that will drive the nifty pharma prediction for monday for 7 September 2026. Their individual performance relative to the broader Nifty 50 trend will determine whether the nifty pharma prediction for monday outperforms or underperforms the benchmark.
